Epigenetics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
- Transparency Market Research
- Ongoing
- Biotechnology
Report Description
The global epigenetics market is projected to reach the value of $18.2
billion by the year 2015 driven by investigation of factors influencing
cellular malfunction and disease development. Also, developments in
epigenetic studies like biomarker discovery and scientifically useful
biomarker tests are expected to support the market growth.
Epigenetics is a rapidly growing field of the biological science
industry and biological researchers are progressively attempting to
discover the process of cells exploiting the information programmed in
genomes. It is the study of regulation of mechanisms other than DNA
sequence over the genomic information programmed in DNA sequence. Recent
discoveries and developments in this field are expected to bring about
major revolution in healthcare industry and treatment of diseases in the
long term.
Although cancer is regarded as mutational disease, it is a major area
for epigenetic diagnostics and therapeutics. Most of the attention in
epigenetic research is focused on DNA methylation and advancements in this
technology are driving the growth of this industry.
Stem cells also represent a growing area in the field of epigenetics.
Epigenetic alterations regulating cell development are enabling researchers
to determine the type of tissues a stem cell turns into.
Market Segmentation
- Bisulfite Conversion Kits
- Chromatin Immunoprecipitation
The epigenetics market research report analyzes this market depending
on its segments and major geographies. Geographies analyzed under this
research report are North America, Asia Pacific, Europe, and Rest of the
World.
This report includes comprehensive analysis of current trends in the
market, industry growth drivers, factors affecting market growth, market
structure, and industry projections for upcoming years. This report also
includes detailed analysis of technological improvements in the field,
Porter’s five force model analysis, and complete company profiles of
top industry players. The report provides review of micro and macro factors
significant with respect to new entrants and existing market players with
value chain analysis.
Major Players
Some of the major players dominating this market are 454 Life
Sciences, Abcam plc, Active Motif Inc., Affymetrix Inc., Agilent
Technologies Inc., AVIVA Systems Biology, Epigenomics AG, GATC Biotech AG,
GeneGo Inc., Human Genetic Signatures Pty. Ltd., Illumina Inc., Millipore,
Orion Genomics LLC, Qiagen N.V., Regulus Therapeutics LLC, Roche Nimblegen,
Rubicon Genomics Inc., Sigma-Aldrich Co., Zymo Research Corp., and
others.
Reasons for Buying this Report
- The report provides technological growth map over time and explains its impact on market
- It provides clear understanding of changing competitive dynamics and keeps you ahead of competitors
- This research report provides overview of major market forces driving and restraining market growth
- It helps in making informed business decisions by making in-depth analysis of market
- It provides distinctive graphics and exemplified SWOT analysis of major industry segments
- It also provides up-to-date analysis of latest trends in market and helps you stay updated with recent technological improvements
- The report provides detailed analysis of major competitors and their strategies
Have query on this report?
Make an Enquiry
Success Stories
Our Clients
More from Biotechnology
Popular Reports
Pharmaceuticals and Healthcare
Global Bionic Ears Market Professional Survey Report 2017Pharmaceuticals and Healthcare
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017Pharmaceuticals and Healthcare
Hepatitis Drug Development Pipeline Review, 2017